News Leflunomide, HCQ Combo Effects Validated in Sjögren Disease by Medscape • 2025/06/18 • 0 Comments The combination of leflunomide and hydroxychloroquine outperformed placebo in reducing disease activity in primary Sjögren syndrome in a second phase II study. Medscape Medical News